Chesterfield Urgent Care Walk-In Clinic
Chesterfield Urgent Care Walk-In Clinic was paid $1.55M by Medicaid between Oct 2019 and Dec 2024, across 22 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
CHESTERFIELD, MI 48051
Next to other Urgent Care Clinic/Center providers in Michigan
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 835 | $43K | |
| 2020 | 2,950 | $147K | |
| 2021 | 8,232 | $346K | |
| 2022 | 8,882 | $376K | |
| 2023 | 8,110 | $342K | |
| 2024incomplete | 7,245 | $297K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 6,600 | 6,214 | $486K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 6,020 | 5,578 | $339K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 19% | 3,172 | 3,161 | $289K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 13% | 3,069 | 3,055 | $199K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.5% | 3,422 | 3,146 | $85K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 901 | 852 | $28K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 1,771 | 928 | $22K |
| 99058 | 1.4% | 329 | 315 | $21K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 1,719 | 1,676 | $19K |
| 87428 | <1% | 792 | 774 | $15K | |
| 99000 | <1% | 5,206 | 4,819 | $15K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 148 | 147 | $10K |
10 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 398 | $9K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 629 | $5K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 113 | $3K |
| 81025 | <1% | 495 | $3K | |
| 81002 | <1% | 1,121 | $3K | |
| 87807 | <1% | 82 | $520.80 | |
| 87210 | <1% | 118 | $411.32 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 94 | $136.49 |
| 36415 | Collection of venous blood by venipuncture | <1% | 43 | $94.27 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $51.10 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.